Physician profile
Luke Smith
NPI 1730991993
$1,783.71
in general payments reported to CMS, 2019-2025
16 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.71 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $243.24 | 2025 | Uptravi, Opsumit, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.30 | 2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $229.72 | 2025 | Dupixent, Evkeeza |
| Abbott Laboratories | $191.67 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $187.57 | 2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $160.42 | 2025 | Verquvo, Capvaxive |
| Stryker Corporation | $150.00 | 2025 | Mako |
| Axsome Therapeutics, INC. | $109.69 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $63.98 | 2025 | |
| Lilly USA, LLC | $59.99 | 2025 | Zepbound, Mounjaro |
| Kestra Medical Technology Services, INC. | $56.08 | 2025 | Assure Wcd |
| Abiomed | $28.82 | 2025 | |
| Boston Scientific Corporation | $21.07 | 2025 | Avvigo Guidance System |
| Bridgebio Pharma, INC. | $20.95 | 2025 | Attruby |
| Chiesi USA, INC. | $15.86 | 2025 | Kengreal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $5.35 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.